维普中文期刊产品整合服务
21篇 您的检索式:作者名="Agema"
    题名 作者 年代 出处 被引量
1Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events 显示文摘Boekholdt SM Agema WR Peters RJ 2003Circulation2003,107,19:1
2Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardio-vascular events显示文摘Boekholdt SM Agema WR Peters RJ 2003Circulation2003,107,:1
3An integrated evaluation of endothelial constitutive nitric oxide synthase polymorphisms and coronary artery disease in men显示文摘Agema WR Maat MP Zwinderman AH 2004Clin Sci(Lond)2004,107,3:1
4Variants of Toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardlovascular events 显示文摘Boekholdt SM Agema WRP Peters RIG 2003Circulation2003,107,19:1
5The causes of dilatedcardiomyopathy : a clinicopathologic review of 673 consecutivepatients显示文摘Kasper EK Agema WR Hutchins GM 1994J Am Coll Cardiol1994,23,3:1
6The causes of dilated cardiomyopathy:a clinicopathologic review of 673 consecutive patients显示文摘Kasper EK Agema WR Hutchins GM 1994J Am Coll Cardiol1994,23,:1
7Variants of toll -like receptor 4 modify the efficacy of statin therapy and the risk of cardio- vascular events 显示文摘Boekholdt SM1 Agema WR Peters R J 2003Circulation2003,107,:1
8Variants of toll-likereceptor 4 modify the efficacy of statin therapy and the risk of car-diovascular events显示文摘Boekholdt SM Agema WR Peters RJ 2003Circulation2003,107,19:1
9Genetic inflammatory factors predict restenosis after percutaneous coronary interventions 显示文摘Monraats PS Pires NM Agema WR 2005Circulation2005,112,16:1
10An integrated evaluation of endothelial constitutive nitric oxide synthase polymorphisms and coronary artery disease in men显示文摘Agema WR de Maat MP Zwinderman AH Kastelein JJ Rabelink TL van Boven AJ 2004Clin Sci(Lond)2004,107,3:1
11Variants of tolllike receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events显示文摘 Agema WR Peters RJ 2003Circulation2003,107,19:1
12Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events显示文摘Boekholdt SM Agema WR Peters RJ 2003Circulation2003,107,:1
13Variants of toll-like receptor4 modify the efficacy of statin therapy and the risk of cardiovascular events显示文摘Boekholdt SM Agema WR Peters RJ Aeilko H Emdst E Pieter H 2003Circulation2003,107,:1
14Pharmacogenetics of the CD14 endotoxin receptor polymorphism and progression of coronary atherosclerosis 显示文摘Agema WRP Jukema JW de Maat MPM 2004Thromb Haemost2004,91,:1
15The causes of dilated cardiomyopathy : a clinicopathologic review of 673 consecutive pa- tients 显示文摘Kasper EK Agema WR Hutchins GM 1994J Am Coil Cardiol1994,23,3:1
16Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events显示文摘Boekholdt SM Agema WR Peters RJ 2003Circulation2003,107,:1
17Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or stroke显示文摘de Bruijn SF Agema WR Lammers GJ 2006Stroke2006,37,:1
18Genetic Inflammatory Factors Predict Restenosis After Percutaneous Coronary Interventions显示文摘Pascalle S. Monraats Nuno M.M. Pires Willem R.P. Agema Aeilko H. Zwinderman Abbey Schepers Moniek P.M. de Maat Pieter A. Doevendans Robbert J. de Winter René A. Tio Johannes Waltenberger Rune R. Frants Paul H.A. Quax Bart J.M. van Vlijmen Douwe E. Atsma A 2005Circulation2005,,:1
19Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events 显示文摘Boekholdt SM Agema WR Peters RJ 2003Circulation2003,107,19:1
20Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events显示文摘Boekholdt SM Agema WR Peters R J 2003Circulation2003,107,19:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费